GuiCom

The ECCO Topical Review on IBD in the ageing population provides guidance on the increasingly recognised challenges of caring for older patients. The review begins by defining 'older adults' and distinguishing between those ageing with longstanding paediatric- or adult-onset disease and those presenting with true elderly-onset IBD.

The latest ECCO Topical Review provides important, practice-oriented guidance on the increasingly recognised entity of drug-induced colitis (DIC), with a particular focus on immune checkpoint inhibitor (ICI)-related disease. DIC is described as a heterogeneous condition that can mimic Inflammatory Bowel Disease both clinically and histologically, making diagnosis challenging. Multiple patterns may coexist, ranging from acute and chronic inflammation to microscopic or ischaemic features, none of which are fully specific.

The new ECCO Guidelines on the Prevention, Diagnosis and Management of Infections in IBD provide an updated framework that builds on and and extends the 2021 ECCO Gguidelines. The document reflects the rapidly evolving therapeutic and infectious disease landscape and is designed as a practical tool for everyday clinical decision-making.

A new ECCO Consensus led by Alaa El-Hussuna highlights challenges and opportunities for improving Inflammatory Bowel Disease (IBD) care in low- and middle-income countries (LMICs): Journal of Crohn's and Colitis, jjaf125, https://doi.org/10.1093/ecco-jcc/jjaf125. With diverse international authorship and ECCO’s support, the project lays the foundation for reducing global inequities in patient care.

One of ECCO’s most impactful contributions to the IBD Community lies in the development of evidence-based guidelines and topical reviews—critical tools that inform and guide clinical decision-making and elevate standards of care.

The European Crohn’s and Colitis Organisation (ECCO), in collaboration with the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the European Society of Pathology (ESP) and the International Bowel Ultrasonography Group (IBUS), has released an updated version of its multi-society guidelines on the diagnostics and monitoring of Inflammatory Bowel Disease (IBD).

The ECCO Guidelines for the management of Crohn’s Disease are among the most influential guidelines informing and guiding patient care worldwide. They are updated every 4 years and their latest iteration is about to be published following a plenary presentation at the recent ECCO Congress in Stockholm.